Moreover, a comprehensive assessment of TP53 pathway across multiple cancer types demonstrated the influence of TP53 mutation on genomic stability29 and the contribution of genomic instability caused by TP53 mutation during ovarian cancer chemoresistance and recurrence has been reported30. This evidence concerns the gene TP53 and cancer.